Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-10-18 THIRD ROCK VENTURES LP 10% owner Other disposition −1,000,000 3,320,348
2017-07-13 THIRD ROCK VENTURES LP 10% owner Other disposition −850,000 4,320,348
2017-03-27 THIRD ROCK VENTURES LP 10% owner Sale −650,000 $18.00 $11.7M 5,170,348
2017-03-23 THIRD ROCK VENTURES LP 10% owner Sale −1,000,000 $17.00 $17.0M 5,820,348
2017-03-15 THIRD ROCK VENTURES LP 10% owner Other disposition −850,000 6,820,348
2016-11-07 THIRD ROCK VENTURES LP 10% owner Other disposition −1,000,000 7,670,348
2015-10-14 THIRD ROCK VENTURES LP 10% owner Conversion +8,670,351 8,670,351
2015-10-14 THIRD ROCK VENTURES LP 10% owner Conversion · Series B-1 Preferred Stock −8,105,314 0
2015-10-14 THIRD ROCK VENTURES LP 10% owner Conversion · Series C Preferred Stock −565,037 0

Page 1 of 1 · 9 trades